About Epicore Biosystems
Epicore Biosystems is a private company based in Cambridge, Massachusetts. It has reported $37,076,103 raised in four offerings on Form D since October 2018. Its chief executive is Roozbeh Ghaffari.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 11, 2024 | Jan 6, 2025amended Apr 7, 2025 | $25,686,104of $35.0M target | 4 | $6.4M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Jan 19, 2024 | Feb 1, 2024 | $1,539,999of $10.0M target | 2 | $769K | EquityRule 506(b) | Form D ↗ |
| Nov 1, 2021 | Nov 3, 2021amended Feb 1, 2022 | $9,500,000of $10.0M target | 5 | $1.9M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Oct 1, 2018 | Oct 16, 2018 | $350,000of $1.0M target | 1 | $350K | EquityRule 506(b) | Form D ↗ |
| Total, four offerings | $37,076,103 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Epicore Biosystems's Form D filed Apr 7, 2025.
SL
Stephen Lee
Executive officer
JR
James Ryan
Executive officer
KQ
Kimberly Querrey
Director
JW
John Wright
Executive officer
JM
Jeffrey Model
Executive officer
RG
Roozbeh Ghaffari
CEO and director
JR
John Rogers
Director
AA
Alexander Aranyosi
Executive officer
WL
Weihua Li
Executive officer
LL
Laura Lang
Director